Hamed K, Alosaimi MN, Ali BA, Alghamdi A, Alkhashi T, Alkhaldi SS et al (2024) Glucagon-like peptide-1 (GLP-1) receptor agonists: exploring their impact on diabetes, obesity, and cardiovascular health through a comprehensive literature review
The COA matches the quality exactly and I am very happy with my results
Google Webfont Settings: Google Map Settings: Google reCaptcha Settings: Vimeo and Youtube video embeds: You can read about our cookies and privacy settings in detail on our Privacy Policy Page
Several pieces of evidence have demonstrated that GIP administration results in an improved glucose-dependent insulin secretion [30, 31]
Its potential to modulate metabolic and neuroprotective pathways offers hope for the development of new therapies that could improve the prognosis of patients with both diseases
doi: 10.1186/s12967-025-06635-8 50